US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY HEALTH CARE ETF

38.69

+0.13000.34%

Post-market: 38.690.00000.00%19:30 EDT

Volume:83.86K

Turnover:3.25M

Market Cap:368.52M

PE:- -

High:39.06

Open:38.84

Low:38.64

Close:38.56

52wk High:40.63

52wk Low:30.61

Shares:9.53M

Float Shares:9.53M

Volume Ratio:0.85

T/O Rate:0.88%

Dividend:0.25

Dividend Rate:0.65%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Femasys announces FDA approval of FemBloc modular premarket approval application

Amylyx Phase 3 data support FDA approval, says Citi

Perimeter Medical Imaging AI Sets Q2 Results Date and Completes Full C$7.52 Million Offering

Perimeter’s AI-Powered Claire Imaging System Lands First Major U.S. Hospital Deployment

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

Fresenius announces FDA approval of rituximab biosimilar

Viatris receives FDA approval for Gwyn Lo contraceptive patch

Freenome, Abbott announce FDA approval of SimpleScreen CRC

Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care

AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.

Victoria's Secret (VSXY) Could Be 24% Overvalued After PINK Marshmallow Bra Launch

Simply Wall St.

Is Victoria's Secret (VSXY) Comfort-First PINK Marshmallow Line the Key to Its Brand Reset?

Simply Wall St.

Amneal receives FDA approval for additional iohexol strengths, presentations

Celcuity announces FDA approval of Revtorpyk

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s

Is Victoria's Secret (VSXY) Expensive After PINK's Marshmallow Bra Launch?

Simply Wall St.

BUUU Group Signs MOU to Explore Acquisition of PINK 308 and Push Into AI-Driven Digital Entertainment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/PINK/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PINK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PINK\",,,,,undefined,":{"symbol":"PINK","market":"US","secType":"STK","nameCN":"SIMPLIFY HEALTH CARE ETF","latestPrice":38.69,"timestamp":1789156800000,"preClose":38.56,"halted":0,"volume":83864,"hourTrading":{"tag":"盘后","latestPrice":38.69,"preClose":38.69,"latestTime":"19:30 EDT","volume":13,"amount":502.97,"timestamp":1789169408611,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.003371369294605691,"floatShares":9525001,"shares":9525001,"eps":0,"marketStatus":"Market Closed","change":0.13,"latestTime":"09-11 16:00:00 EDT","open":38.84,"high":39.0551,"low":38.64,"amount":3250284.3410400003,"amplitude":0.010765,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":38.56,"sharesOutstanding":7975001,"nav":38.5598,"aum":358592074.58,"dividendRate":0.006464,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":38.56,"preClose":38.56,"latestTime":"07:36 EDT","volume":1,"amount":38.56,"timestamp":1789126570040,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":38.69,"preClose":38.69,"latestTime":"19:30 EDT","volume":13,"amount":502.97,"timestamp":1789169408611,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8506218579601067,"impliedVol":0.2238,"impliedVolPercentile":0.9124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PINK\",,,,,undefined,":{"symbol":"PINK","floatShares":9525001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8506218579601067,"shares":9525001,"dividePrice":0.2501,"high":39.0551,"amplitude":0.010765,"preClose":38.56,"low":38.64,"week52Low":30.61,"pbRate":"--","week52High":40.63,"institutionHeld":0,"latestPrice":38.69,"eps":0,"divideRate":0.006464,"volume":83864,"delay":0,"ttmEps":0,"open":38.84,"prevYearClose":36.6,"prevWeekClose":39.7216,"prevMonthClose":39.31,"prevQuarterClose":39.15,"fiveDayClose":39.85,"twentyDayClose":39.8179,"sixtyDayClose":36.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PINK\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"PINK","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"PINK","amount":0.05,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-09-25","symbol":"PINK","amount":0.05,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"PINK","amount":0.05,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-30"},{"date":"2025-03-26","symbol":"PINK","amount":0.05,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PINK\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-27","recordDate":"2021-12-28","paymentDate":"2021-12-30","value":0.0117,"currency":"USD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-03-31","value":0.03535,"currency":"USD"},{"executeDate":"2022-06-27","recordDate":"2022-06-28","paymentDate":"2022-06-30","value":0.02945,"currency":"USD"},{"executeDate":"2022-09-27","recordDate":"2022-09-28","paymentDate":"2022-09-30","value":0.03121,"currency":"USD"},{"executeDate":"2022-12-27","recordDate":"2022-12-28","paymentDate":"2022-12-30","value":0.01698,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PINK\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PINK\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660252964","title":"Femasys announces FDA approval of FemBloc modular premarket approval application","url":"https://stock-news.laohu8.com/highlight/detail?id=2660252964","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660252964?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:16","pubTimestamp":1787145413,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that the FDA has approved the company’s modular premarket approval application pathway for FemBloc, its investigational no...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","PINK","XLVX","PSCH","FRTY","BBP","LFSC","BMED","MEDI","BK4585","TBXU","MRNY","SYNB","IYH","BK4584","GDOC","IDNA","FEMY","NVIB","BK4082","BK4539","BK4588","IEIH","GNMX","TECB","MRNX","LABU","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660595493","title":"Amylyx Phase 3 data support FDA approval, says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660595493","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660595493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:05","pubTimestamp":1787061936,"startTime":"0","endTime":"0","summary":"Citi says Amylyx’s (AMLX) avexitide showed a “highly differentiated” profile in the Phase 3 LUCIDITY study, a 78 participant, placebo-controlled tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4585","IDNA","IEIH","LABU","MEDI","BK4588","BBP","NVIB","GDOC","TECB","FRTY","SYNB","PSCH","XLVX","IBB","GNMX","AMLX","BK4007","TBXU","MRNX","PINK","MRNY","LFSC","IYH","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659949195","title":"Perimeter Medical Imaging AI Sets Q2 Results Date and Completes Full C$7.52 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2659949195","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659949195?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:10","pubTimestamp":1786662641,"startTime":"0","endTime":"0","summary":"Perimeter Medical Imaging AI ( ($TSE:PINK) ) just unveiled an update. Perimeter Medical Imaging AI said it will release its second-quarter 2026 fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/perimeter-medical-imaging-ai-sets-q2-results-date-and-completes-full-c7-52-million-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/perimeter-medical-imaging-ai-sets-q2-results-date-and-completes-full-c7-52-million-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","VTHR","AGIX","QTOC","AIPO","ARTY","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659501161","title":"Perimeter’s AI-Powered Claire Imaging System Lands First Major U.S. Hospital Deployment","url":"https://stock-news.laohu8.com/highlight/detail?id=2659501161","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659501161?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:39","pubTimestamp":1786628395,"startTime":"0","endTime":"0","summary":"Perimeter Medical Imaging AI ( ($TSE:PINK) ) has provided an announcement. Perimeter Medical Imaging AI has secured a key commercial deployment for...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/perimeters-ai-powered-claire-imaging-system-lands-first-major-u-s-hospital-deployment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/perimeters-ai-powered-claire-imaging-system-lands-first-major-u-s-hospital-deployment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTOC","PINK","VTHR","AIPO","CHAT","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659926188","title":"Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659926188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659926188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:37","pubTimestamp":1786567029,"startTime":"0","endTime":"0","summary":"The latest update is out from Outlook Therapeutics ( ($OTLK) ). On July 24, 2026, Outlook Therapeutics announced U.S. FDA approval of LYTENAVA (bev...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","XLVX","MRNY","PSCH","IYH","BMED","FRTY","BK4588","IDNA","BK4539","IEIH","SYNB","LENZ","GDOC","RSPH","TECB","LFSC","GNMX","BK4585","BK4139","NVIB","BK4007","LABU","PINK","MEDI","TBXU","BBP","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657572786","title":"Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572786?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:25","pubTimestamp":1785972320,"startTime":"0","endTime":"0","summary":"The latest update is out from Takeda Pharmaceutical Co ( ($JP:4502) ). Takeda has secured U.S. FDA approval for ORZEYFUL, an oral orexin receptor 2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","RSPH","PSCH","XLVX","IEIH","BBP","MRNY","FRTY","PINK","SYNB","BK4585","IYH","IDNA","LFSC","IBB","GNMX","MRNX","BK4588","TECB","MEDI","GDOC","LABU","BMED","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184959126","title":"Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination","url":"https://stock-news.laohu8.com/highlight/detail?id=1184959126","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184959126?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:21","pubTimestamp":1785878467,"startTime":"0","endTime":"0","summary":"Amgen reported its second-quarter earnings after the U.S. stock market close on Tuesday, with robust drug sales boosting profits, leading the company to raise its full-year outlook. However, it also...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","LU2242646821.SGD","IE0002141913.USD","LU1061106388.HKD","LU1057294990.SGD","PINK","BK4139","PJP","LU0868494617.USD","BBH","LU0889565916.HKD","SG9999001440.SGD","LU2089984988.USD","BK4585","IBB","LU0109394709.USD","LU2468319806.SGD","NBDS","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1023059063.AUD","NVOC","MEDI","LU2112291526.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","FHLC","BIB","BK4581","IE00BJJMRZ35.SGD","BK4534","THNR","BK4566","LU0289739699.SGD","XLVI","IBBQ","IYH","CURE","BK4533","BK4599","TRUH","RSPH","LU0058720904.USD","LU0122379950.USD","AMGN","LU2242652126.USD","FXH","TBXU","PBE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304376","title":"Fresenius announces FDA approval of rituximab biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304376?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:15","pubTimestamp":1785788150,"startTime":"0","endTime":"0","summary":"Fresenius Kabi, an operating company of Fresenius (FSNUY), announced that the U.S. Food and Drug Administration has approved a rituximab biosimilar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","TBXU","BK4585","FSNUY","BBP","LFSC","SYNB","GNMX","MRNY","BMED","NVIB","IYH","PSCH","RSPH","FRTY","IBB","IEIH","GDOC","TECB","XLVX","IDNA","MRNX","BK4588","MEDI","PINK","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655895830","title":"Viatris receives FDA approval for Gwyn Lo contraceptive patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2655895830","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655895830?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:16","pubTimestamp":1785330964,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) announced that the FDA has approved Gwyn Lo, a new combined hormonal contraceptive patch with low-dose estrogen. The patch has demon...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","TECB","BK4588","BK4583","FRTY","SYNB","GDOC","MEDI","NVIB","LU1839511570.USD","LU2087621335.USD","BBP","RSPH","GNMX","TBXU","IDNA","BMED","IBB","MRNX","IEIH","IYH","LFSC","BK4585","VTRS","PSCH","MRNY","XLVX","PINK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010379","title":"Freenome, Abbott announce FDA approval of SimpleScreen CRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010379","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010379?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:16","pubTimestamp":1785154580,"startTime":"0","endTime":"0","summary":"Freenome (FRNM) and Abbott (ABT) announced that the FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","MEDI","TBXU","LU2468319806.SGD","IDNA","BK4588","GDOC","LU2112291526.USD","LU1061106388.HKD","LU1914381329.SGD","BK4504","BK4082","LU0266013472.USD","NVIB","PINK","TECB","BK4585","IE0002141913.USD","SGXZ41872573.SGD","XLVX","LU1721429741.USD","PJP","MRNY","SG9999002232.USD","PSCH","IYH","GNMX","CRC","LU2324357040.USD","IBB","IHI","LU0868494617.USD","LU0170899867.USD","SYNB","LU0266512127.USD","MRNX","LFSC","TMED","LU1691799644.USD","FRNM","FRTY","SG9999002224.SGD","BK4213","RSPH","LU1721429402.USD","BMED","LABU","ABT","IEIH","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277792","title":"Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277792?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635200,"startTime":"0","endTime":"0","summary":"Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announcedASC Solutions: an expanded enterprise strategy for ambulatory surgery centers (ASCs) that takes a customer-cent","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/21/3330395/0/en/Smith-Nephew-introduces-expanded-enterprise-ASC-Solutions-Strategy-to-support-growth-performance-and-value-based-care.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNN","IEHS","LU1983260115.SGD","LU1093756168.USD","PINK","LU1093756325.SGD","FXH","BK4585","LU0390134368.USD","XHS","LU0266013472.USD","ASC","SG9999014005.SGD","SG9999014021.USD","BK4533","LU0211331839.USD","BK4082","BK4144","SG9999014013.SGD","LU0238689110.USD","TCAF","LU0070302665.USD","HUM","IHF","BK4566","LU0170899867.USD","BK4154","LU0256863811.USD","LU0208291251.USD","LU0348723411.USD","BK4588","LU0417517546.SGD","LU0320765489.SGD","UNHU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653529241","title":"AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2653529241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653529241?lang=en_us&edition=fundamental","pubTime":"2026-07-21 06:47","pubTimestamp":1784587635,"startTime":"0","endTime":"0","summary":"An announcement from AFT Pharmaceuticals Ltd. ( ($NZ:AFT) ) is now available. AFT Pharmaceuticals has received tentative U.S. FDA approval for Scom...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","MRNY","LABU","RSPH","TECB","GDOC","MRNX","IBB","SYNB","IDNA","BK4588","BMED","PSCH","IYH","FRTY","LFSC","BBP","MEDI","AFT","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652057218","title":"Victoria's Secret (VSXY) Could Be 24% Overvalued After PINK Marshmallow Bra Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2652057218","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652057218?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:20","pubTimestamp":1784542825,"startTime":"0","endTime":"0","summary":"Victoria's Secret (VSXY) is back in focus after its PINK brand introduced the Marshmallow Bra Collection, a comfort-led lineup of wireless styles and inclusive sizing that broadens the company’s intimate apparel offering.\nSee our latest analysis for Victoria's Secret.\nThe product news lands as Victoria's Secret trades at US$81.45, with the share price up 48.31% over 90 days and a 1-year total shareholder return of more than 3x, which points to strong recent momentum.\nIf this kind of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4441000-choice2-main-header/1585186771078","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4441000-choice2-main-header/1585186771078"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nyse-vsxy/victorias-secret/news/victorias-secret-vsxy-could-be-24-overvalued-after-pink-mars","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nyse-vsxy/victorias-secret/news/victorias-secret-vsxy-could-be-24-overvalued-after-pink-mars","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4094","VSXY","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652844892","title":"Is Victoria's Secret (VSXY) Comfort-First PINK Marshmallow Line the Key to Its Brand Reset?","url":"https://stock-news.laohu8.com/highlight/detail?id=2652844892","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652844892?lang=en_us&edition=fundamental","pubTime":"2026-07-17 23:25","pubTimestamp":1784301957,"startTime":"0","endTime":"0","summary":"In early July 2026, Victoria’s Secret PINK launched Marshmallow, a new comfort-focused bra collection featuring four wireless silhouettes in inclusive sizes from XXS–XXL and SDD–LDD, priced between US$29.95 and US$49.95.\nBy emphasizing buttery soft, four-way stretch fabrics, pull-on designs, and lifestyle-specific wear, Marshmallow deepens PINK’s comfort and versatility positioning within Victoria’s Secret’s broader bra portfolio.\nNext, we’ll explore how this comfort-centric, inclusive...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4441000-choice2-main-header/1585186771078","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4441000-choice2-main-header/1585186771078"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nyse-vsxy/victorias-secret/news/is-victorias-secret-vsxy-comfort-first-pink-marshmallow-line","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nyse-vsxy/victorias-secret/news/is-victorias-secret-vsxy-comfort-first-pink-marshmallow-line","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4094","VSXY","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652882192","title":"Amneal receives FDA approval for additional iohexol strengths, presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2652882192","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652882192?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290509,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) announced that it has received FDA approval for additional strengths and vial presentations of iohexol injection, 350...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BMED","GDOC","LFSC","TECB","IYH","PINK","FRTY","IBB","RSPH","BBP","PSCH","MRNY","MRNX","AMRX","BK4007","BK4585","MEDI","IDNA","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","GDOC","MRNY","SYNB","LABU","PINK","BMED","TECB","IYH","MEDI","BBP","IBB","PSCH","LFSC","BK4139","CELC","BK4585","FRTY","IDNA","MRNX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","CAI","LABU","LFSC","PSCH","PTEN","BK4588","SYNB","BK4162","RSPH","TECB","FRTY","IBB","IYH","BMED","IHC","BBP","BK4585","MRNX","PINK","BK4092","IDNA","BK4139","MEDI","GDOC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0499858438.USD","LU2152927971.USD","BK4211","BK4535","BK4220","BK4588","MRNX","LU2065170008.USD","IBB","LU0251143029.SGD","LU0516423174.USD","LU2125910849.SGD","BBP","SE","LU0532188223.SGD","LU0441851309.USD","SG9999002679.SGD","LU0823039010.USD","MEDI","SG9999002414.USD","LU2065171402.SGD","BMED","LABU","LU0516423091.SGD","SG9999014484.SGD","TECB","LFSC","BK4554","FRTY","GDOC","HBCP","MRNY","PSCH","SG9999002406.SGD","LU0589944569.HKD","BK4585","FDNI","LU1861220207.SGD","IE0031814969.USD","LU0516422366.SGD","BK4503","SG9999014492.USD","SYNB","IDNA","IYH","LU2360107671.USD","SG9999013478.USD","SG9999002620.SGD","PINK","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650168170","title":"Is Victoria's Secret (VSXY) Expensive After PINK's Marshmallow Bra Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650168170","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650168170?lang=en_us&edition=fundamental","pubTime":"2026-07-12 14:22","pubTimestamp":1783837328,"startTime":"0","endTime":"0","summary":"Victoria's Secret (VSXY) stock is drawing fresh attention after PINK introduced its Marshmallow Bra Collection, a comfort-focused lineup that broadens the brand’s existing bra franchises with four wireless, lifestyle-oriented styles.\nSee our latest analysis for Victoria's Secret.\nAt a share price of $78.36, Victoria's Secret has seen momentum build, with a 56.91% 90 day share price return and a very large 1 year total shareholder return of 309.40%, while the Marshmallow launch adds another...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4441000-choice2-main-header/1585186771078","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4441000-choice2-main-header/1585186771078"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nyse-vsxy/victorias-secret/news/is-victorias-secret-vsxy-expensive-after-pinks-marshmallow-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nyse-vsxy/victorias-secret/news/is-victorias-secret-vsxy-expensive-after-pinks-marshmallow-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","VSXY","BK4094","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955670","title":"BUUU Group Signs MOU to Explore Acquisition of PINK 308 and Push Into AI-Driven Digital Entertainment","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955670","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955670?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:58","pubTimestamp":1777899486,"startTime":"0","endTime":"0","summary":"BUUU Group Limited Class A ( ($BUUU) ) has shared an update. On May 4, 2026, BUUU Group Limited announced it has signed a non-binding memorandum of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/buuu-group-signs-mou-to-explore-acquisition-of-pink-308-and-push-into-ai-driven-digital-entertainment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/buuu-group-signs-mou-to-explore-acquisition-of-pink-308-and-push-into-ai-driven-digital-entertainment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIPO","BK4009","BUUU","ARTY","AGIX","CHAT","PINK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}